Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Biochem Sci. 2001 Nov;26(11):672-8.

beta-catenin: molecular plasticity and drug design.

Author information

1
Dept of Structural Biology, Stanford University School of Medicine 299 Campus Dr., West Stanford, CA 94305, USA.

Abstract

The protein beta-catenin is an essential component of intercellular junctions and the Wnt growth factor signaling pathway. In many cancers, mutation of Wnt pathway components leads to activation of oncogenes by the beta-catenin-Tcf transcription factor complex. This complex is therefore an attractive target for anti-cancer drugs, but any such compound must selectively interfere with the beta-catenin-Tcf complex without disrupting other essential interactions of beta-catenin. Recent structural and biochemical studies have probed the molecular basis of ligand interaction by beta-catenin, and highlighted the possibilities and challenges of designing inhibitors of the beta-catenin-Tcf complex.

PMID:
11701326
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center